Provided by Tiger Fintech (Singapore) Pte. Ltd.

Geron

1.43
+0.08005.93%
Post-market: 1.40-0.0300-2.10%19:52 EDT
Volume:17.15M
Turnover:24.39M
Market Cap:912.36M
PE:-10.80
High:1.47
Open:1.37
Low:1.34
Close:1.35
52wk High:4.83
52wk Low:1.09
Shares:638.02M
Float Shares:538.90M
Volume Ratio:1.10
T/O Rate:3.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1324
EPS(LYR):-0.2702
ROE:-31.09%
ROA:-9.63%
PB:3.52
PE(LYR):-5.29

Loading ...

Geron Second Quarter 2025 Earnings: Beats Expectations

Simply Wall St.
·
Aug 11

BRIEF-Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Aug 09

Geron Corporation Files Initial Statement of Beneficial Ownership for Harout Semerjian, President and CEO

Reuters
·
Aug 09

Geron Corporation Announces Inducement Grant of Stock Options to New CEO Harout Semerjian

Reuters
·
Aug 09

Positive Momentum and Strategic Leadership Drive Buy Rating for Geron Amid Growing Demand for Rytelo

TIPRANKS
·
Aug 08

Scotiabank Reaffirms Their Hold Rating on Geron (GERN)

TIPRANKS
·
Aug 07

Geron (GERN) Gets a Buy from Barclays

TIPRANKS
·
Aug 07

Geron’s Positive Trajectory and Strategic Growth Justify Buy Rating

TIPRANKS
·
Aug 06

Geron Names Harout Semerjian CEO

MT Newswires Live
·
Aug 06

Geron Corp reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 06

BRIEF-Geron Appoints Harout Semerjian As President And Chief Executive Officer

Reuters
·
Aug 06

Geron Q2 Net Loss Widens, Revenue Rises

MT Newswires Live
·
Aug 06

Earnings Flash (GERN) Geron Posts Q2 Net Loss $0.02 a Share, vs. FactSet Est of $0.03 Loss

MT Newswires Live
·
Aug 06

Biopharma firm Geron's Q2 product revenue rises, net loss narrows

Reuters
·
Aug 06

Geron Q2 EPS USD -0.02

Reuters
·
Aug 06

Stock Track | Geron Soars 5.83% Pre-market on Strong Q2 Product Revenue of $49 Million

Stock Track
·
Aug 06

Stock Track | Geron Soars 5.83% Pre-market on Strong Q2 Product Revenue Despite Net Loss

Stock Track
·
Aug 06

Geron Corp - Dawn Carter Bir Steps Down as Interim President and CEO

THOMSON REUTERS
·
Aug 06

Cautiously Optimistic: Geron’s Strategic Changes and Growth Prospects Support Buy Rating

TIPRANKS
·
Jul 21

Analysts Offer Insights on Healthcare Companies: Geron (GERN) and Ramsay Health Care (OtherRMSYF)

TIPRANKS
·
Jul 21